- Home
- /
- Treatment
- /
- Page 75
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Hantaan virus and Puumala virus DNA vaccines | Prevention of hemorrhagic fever with renal syndrome caused by Hantaan virus and Puumala virus | Surgeon General of the U. S. Army;1430 Veterans Drive, ATTN: USAMR and MC;Fort Detrick, Maryland, 21702 | November 13, 2012 | |
Crizotinib | Neuroblastoma | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 | October 31, 2012 | |
5′-GCCATGGTTTTTTCTCAGG-3′ | Prophylaxis for patients following documented or suspected exposure to ebolavirus | Sarepta Therapeutics, Inc.;215 First Street;Cambridge, Massachusetts, 02142 | October 31, 2012 | |
(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid | Primary biliary cirrhosis | Albireo AB;Arvid Wallgrens Backe 20, S-413 46 Gothenburg; | October 31, 2012 | |
Coagulation factor IX (recombinant) | Hemophilia B | Baxalta US, Inc.;One Baxter Way;Westlake Village, California, 91362 | October 31, 2012 | |
(2S)-2-{[(2R)-2-[({[3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro- 1,2,5-benzothiadiazepin-8-yl]oxy}acetyl)amino]-2-(4-hydroxyphenyl)acetyl]amino}butanoic acid | Progressive familial intrahepatic cholestatis | Albireo AB;Arvid Wallgrens Backe 20, S-413 46 Gothenburg; | October 31, 2012 | |
2′-O-methyl phosphorothioate 5′-GCUAGGUUUACGGGACCUCU-3′ | Amyotrophic lateral sclerosis | LifeSplice Pharma LLC;1 Great Valley Parkway, Suite 20;Malvern, Pennsylvania, 19355 | October 31, 2012 | |
5ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬”-GAATATTAACAIACTGACAAGTC-3ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬” | Prophylaxis following documented or suspected exposure to marburg virus | Sarepta Therapeutics, Inc.;215 First Street;Cambridge, Massachusetts, 02142 | October 31, 2012 | |
Crenolanib | Acute myeloid leukemia | AROG Pharmaceuticals, LLC;12400 Coit Road, Suite 570;Dallas, Texas, 75251 | October 31, 2012 | |
5ÿÂâÿì”-GAATATTAACAIACTGACAAGTC-3ÿÂâÿì” | Prophylaxis following documented or suspected exposure to marburg virus | Sarepta Therapeutics, Inc.;215 First Street, Suite 7;Cambridge, MA, 02142 | October 31, 2012 | |
5ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬”-GAATATTAACAIACTGACAAGTC-3ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬” | Prophylaxis following documented or suspected exposure to marburg virus | Sarepta Therapeutics, Inc.;215 First Street, Suite 415;Cambridge, Massachusetts, 02142 | October 31, 2012 | |
5ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬”-GAATATTAACAIACTGACAAGTC-3ÿ¿ÿÿÿ¢ÿ¿ÿÿ¬” | Prophylaxis following documented or suspected exposure to marburg virus | Sarepta Therapeutics, Inc.;215 First Street, Suite 415;Cambridge, Massachusetts, 02142 | October 31, 2012 | |
Crizotinib | Anaplastic large cell lymphoma | Pfizer, Inc.;10646 Science Center Drive;San Diego, California, 92121 | September 28, 2012 | |
ADF-APO-CCN-GUC-K67-MET-MMP-MUC-RGS; HLA class I/II binding tumor associated peptides | Renal cancer | Immatics Biotechnologies GmbH;Paul-Ehrlich-Strasse 15, 72072 Tubingen; | September 28, 2012 | |
Liposomal �}±-galactosylceramide | Graft Versus Host Disease | REGiMMUNE Corporation;320 Logue Avenue;Mountain View, California, 94043 | September 28, 2012 | |
Carbon monoxide | Sickle cell anemia | Hillhurst Biopharmaceuticals, Inc.;2029 Verdugo Blvd, Suite 125;Montrose, California, 91020 | September 28, 2012 | |
Amatuximab | Malignant pleural mesothelioma | Morphotek, Inc.;210 Welsh Pool Road;Exton, Pennsylvania, 19341 | September 28, 2012 | |
Japanese encephalitis vaccine, inactivated, adsorbed | Japanese encephalitis | Intercell AG;Campus Vienna Biocenter 3, A-1030;Vienna | September 25, 2012 | |
Synthetic double-stranded siRNA oligonucleotide against caspase 2 mRNA | Anterior ischemic optic neuropathy | Quark Pharmaceuticals, Inc.;6501 Dumbarton Circle;Fremont, California, 94555 | September 25, 2012 | |
Dantrolene sodium | Heat stroke | Eagle Pharmaceuticals, Inc.;50 Tice Blvd, Suite 315;Woodcliff Lake, New Jersey, 07677 | September 25, 2012 | |
H-Leu-Pro-Pro-Ser-Arg-OH | Kaposi sarcoma | Immuno Tech, Inc.;6329 256th Street, NE;Arlington, Washington, 98223 | September 20, 2012 | |
4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | Chronic lymphocytic leukemia | AbbVie, Inc.;1 N. Waukegan Rd.;North Chicago, IL, 60064 | September 20, 2012 | |
Venetoclax | Chronic lymphocytic leukemia | AbbVie, Inc;1 North Waukegan Road, Dept. PA77, Bldg. AP30-1;North Chicago, Illinois, 60064 | September 20, 2012 | |
Alfimeprase | ST-elevation myocardial infarcted patients who are undergoing primary percutaneous coronary intervention | Niche Therapeutics, LLC;2009 Morton Avenue;Ann Arbor, Michigan, 48104 | September 20, 2012 | |
Canakinumab | TNF-receptor associated periodic syndrome (TRAPS) | Novartis Pharmaceuticals Corporation;One Health Plaza;East Hanover, New Jersey, 07936 | September 4, 2012 |